A Study of ALN-HSD in Healthy Adult Subjects & Adult Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT03375008` - Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)	N/A
Recruiting	`NCT05979779` - Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis	Phase 2
Withdrawn	`NCT02769091` - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes	Phase 2
Completed	`NCT02654977` - CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy	Phase 2
Recruiting	`NCT05211284` - Saroglitazar Magnesium 4 mg for NASH in People Living With HIV in the US	Phase 2
Completed	`NCT02421094` - Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis	Phase 2
Completed	`NCT01205087` - Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome	Phase 2
Recruiting	`NCT00152711` - Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis	N/A
Completed	`NCT02217475` - Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis	Phase 2
Completed	`NCT04031729` - Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease	Phase 1/Phase 2
Completed	`NCT03674476` - An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function	Phase 1
Recruiting	`NCT03725631` - Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD	N/A
Completed	`NCT01679197` - Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy	Phase 2
Active, not recruiting	`NCT05084404` - Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease	Phase 2
Active, not recruiting	`NCT02574325` - A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis	Phase 2
Terminated	`NCT00878592` - Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity	N/A
Recruiting	`NCT02148471` - Fatty Acids, Genes and Microbiota in Fatty Liver	N/A
Completed	`NCT00227110` - Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)	Phase 4
Completed	`NCT03656744` - A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)	Phase 2
Completed	`NCT03068078` - A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes	N/A

NCT number	NCT04565717
Study type	Interventional
Source	Alnylam Pharmaceuticals
Contact
Status	Terminated
Phase	Phase 1
Start date	October 9, 2020
Completion date	December 21, 2023

A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms